HomeAI · summaries
Storia in 6 fonti
Lilly to buy TED startup Merida Biosciences in its 13th acquisition of 2026
Eli Lilly acquires Merida Biosciences for up to $2.875B, gaining MER511 for thyroid eye disease/Graves' disease and MER769 for allergic conditions like asthma.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
biopharmadive.com
Lilly adds to immune drug pipeline with $2.9B Merida buyout
The big drugmaker’s latest company acquisition this year is centered around a technology designed to degrade proteins that malfunction in autoimmune disorders.
- ·
qz.com
Eli Lilly buying Merida Biosciences for up to $2.875 billion
The deal adds a pipeline targeting the antibodies behind Graves' disease, thyroid eye disease, food allergy, and other conditions
